子宮平滑肌瘤:鐘剛-課件_第1頁(yè)
子宮平滑肌瘤:鐘剛-課件_第2頁(yè)
子宮平滑肌瘤:鐘剛-課件_第3頁(yè)
子宮平滑肌瘤:鐘剛-課件_第4頁(yè)
子宮平滑肌瘤:鐘剛-課件_第5頁(yè)
已閱讀5頁(yè),還剩48頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

LeiomyomaofUterusZhonggangDepartmentofGynecologyandObstetricTongjiHospitalLeiomyomaofUterusZhonggang1Introduction

Uterineenlargementasaresultofleiomyomaiscommoninclinicalpractice.Myomaarethecommonestnewgrowthsoftheuterusandoneofthemostcommontumorsofthehumanbody.Theseoccurinapproximately,20%ofwomenover30,25%ofwomenover40.IntroductionUterineenlargeme2AetiologicalfactorsFemaleHormonesEstrogensProgestronsGrowthFactorsBasicfibroblastgrowthfactor(BFGF).Insulinlikegrowthfactor(IGF)-I.Epidermalgrowthfactor(EGF).AetiologicalfactorsFemaleHor3AnatomyofuterusAnatomyofuterus4ClassificationClassification5ClassificationAccordingtolocationofuterinemyomatahavebeendividedinCorporealfibromyomata(90%)Cervicalmyomata(10%).ClassificationAccordingtoloc6ClassificationAndcorporealmyomatahavebeendivided:Intramuralfibromymata60-70%Subserousfibromymata20%Submucousfibromymata10-15%ClassificationAndcorporealmy7子宮平滑肌瘤:鐘剛-課件8ClassificationIntramuralfibromymata

withintramuralfibromyomataenlargementoftheuterinebodyusuallyoccurs,oftenwithelongationofitscavitysothatthereisincreasedmenstrualloss.ClassificationIntramuralfibro9Classification

Subserousfibromymata

Size:fromsmallnodulestoenormousmassesof20kgormoreinweight.Pedunculatedmyoma:theytendtogrowupintotheabdomenandthebroadligament,Rarelytorsionmayoccur,resultingininterferencewiththebloodsupplytothetumor.ClassificationSubserousfib10ClassificationSubmucousfibromyoma.Someintramuraltumorsareextrudedtowardstheuterinecavity.Theuteruscontractsinanattempttoexpelthetumoranditmaybeextrudeduntilitisonlyattachedtotheuterinewallbyastalkandisknownasafibro-myomatouspolypClassificationSubmucousfibrom11PathologyNackedeyeappearance.onsectionthefibromyomaispaler,harderandmorefibrousthantheuterinewall.Oncomparinganintramuraltumorwiththesurroundingfalsecapsuleofuterinewallthedifferenceiswellmarked.PathologyNackedeyeappearance12NackedeyeappearanceNackedeyeappearance13Smoothmuscletumorsoftheuterusareoftenmultiple.Seenherearesubmucosal,intramural,andsubserosalleiomyomataoftheuterus.Smoothmuscletumorsoftheut14PathologyMicroscopicalstructure.ThesegrowthsarecomposedofunstripedmuscleandfibroustissuePathologyMicroscopicalstructu15Hereisthemicroscopicappearanceofabenignleiomyoma.Normalmyometriumisattheleft,andtheneoplasmiswell-differentiatedsothattheleiomyomaattherighthardlyappearsdifferent.Bundlesofsmoothmuscleareinterlacinginthetumormass.Hereisthemicroscopicappear16DegenerationThesetumorsgrowslowly;insomecasestheremaybenoevidentchangeinsizeformanyyears.Inafewcasesgrowthismorerapidandsecondarychangesmayalsocauseswellingofthetumor.DegenerationThesetumorsgrow17DegenerationHyalinedegenerationisthecommonestchangeseeninfibromyomata.Itiscausedbyagradualinadequacyofthebloodsupply.Cysticdegenerationisnotuncommon,especiallyafterthemenopause,andisduetoliquefactionoftheareasofhyalinechange.DegenerationHyalinedegenerati18DegenerationReddegeneration.Inthisvarietyofdegenerationtheaffectedareaisstainedredandresemblesrawmeat.Itismostfreguentlyseenduringthepregnancyandinpostpartum.DegenerationReddegeneration.19Degeneration

Malignantchange

In0.1to1%ofcases,malignancyasleiomyosarcomamaydevelop.Itismostlikelytobeseeninlargetumors.Malignancyismoretypicalinolderpatients,especiallypostmenopausalpatientsPresentionwithrapidlyenlarginguterinemassandpostmenopausalbleeding.Metastasisoccursrapidllyinthesecases.DegenerationMalignantchang20Thisisaleiomyosarcomaprotrudingfrommyometriumintotheendometrialcavityofthisuterusthathasbeenopenedlaterallysothatthehalvesofthecervixappearatrightandleft.Fallopiantubesandovariesprojectfromtopandbottom.Theirregularnatureofthismasssuggeststhatisnotjustanordinaryleiomyoma.Thisisaleiomyosarcomaprotr21SymptomsBleedingisthemostcommonpresentingsymptominuterinefibroids.Menorrhagiaisfreguentreasonforpatientstoseekadvice.Theperiodsincreaseinamountandduration.SymptomsBleedingisthemostc22SymptomsBleeding

Submucousfibromyomatamenorrhagiaisnearlyalwayspresent,andquitesmalltumorscanleadtosevereanaemia.IntramuraltumorsmayincreasethelossSubserousgrowthsdonotaffectthemenstrualloss.SymptomsBleeding23SymptomsBleeding

Mechanismsforincreasedbleeding:AlterationofnormalmyometrialcontractilefunctionInabilityoftheoverlyingendometriumtorespondtothenormalE/Pmenstrualphases.Pressurenecrosisoftheoverlyingendometrialbed.SymptomsBleeding24SymptomsAnabdominaltumourissometimesthefirstthingthatthepatientnotices.Thetumorisnottenderandrarelygivesrisetopain.Dischargeisrarelyaprominentsymptomexceptduringtheextrusionoffibromyomatospolypthroughthecervicalcanal.SymptomsAnabdominaltumouris25SymptomsPainisnotacommonsymptom.whenitoccuritisgenerallyanindicationthatthereisassociatedendometriosisorpelvicinflammatorydisease,orsomecomplicationofthetumorsuchasreddegenerationortorsion.SymptomsPainisnotacommons26SymptomsPelvicpressure:pressureonthebladderleadingtofrequencyandretentionofurine.SymptomsPelvicpressure:press27PhysicalsignsThephysicalsignsvarywiththesize,positionandnumberofthetumors.Asymmetricalenlargementoftheuterusisfoundwithasubmucosgrowth.Moreoftentheenlargementisasymmetrical;itisoftennodularonthesurfacebecausetherearemultipletumor.Subseroustumorswithlittlemyometrialcoveringoftenfellparticularlyhard.PhysicalsignsThephysicalsig28PhysicalsignsOnpelvicexaminationthecervixmaybefoundtobepusheddownordisplacedtooneside.Ifitisexpandedbyanintracervicaltumor,oritmaybedilatedwiththelowerpoleofatumorleftwithinit.PhysicalsignsOnpelvicexamin29DiagnosisThediagnosisofthesetumorsisusuallymadebyclinicalexamination,includeabdominalandbimanualpalpation,orimagingstudies.Inaddition,irregularitiesoftheuterinecavitycanbedetectedatthetimeofendometrialcurrettage.DiagnosisThediagnosisofthes30DiagnosisPelvicultrasoundisthemostcommonlyusedforconfirmationofuterinemyomas.Dilationandcurettagemayproviderelevantinformation,becauselargertissuespecimens,includingsmallsubmucousmyomas,maybeobtained.DiagnosisPelvicultrasoundis31PelvicultrasoundPelvicultrasound32PelvicultrasoundPelvicultrasound33HysteroscopyHysteroscopymayalsobeusedtoevaluatetheenlargeduterusbydirectlyvisualizingtheendometrialcavity.HysteroscopyHysteroscopymaya34DifferentialdiagnosisOtherconditionswhichcausemenorrhagiaDysfunctionaluterinebleedingCarcinomaoftheuterusEndometrialpolypofuterusOtherconditionswhichgiverisetoaswellinginthepelvisAdenomyoma,ovariantumors,inflammatoryswellinginthepelvis,pregnancyDifferentialdiagnosisOtherco35Thisuterushasbeenopenedanteriorlythroughcervixandintotheendometrialcavity.Highinthefundusandprojectingintotheendometrialcavityisasmallendometrialpolyp.Suchbenignpolypsmaycauseuterinebleeding.Thisuterushasbeenopenedan36Thethickenedandspongyappearingmyometrialwallofthissectioneduterusistypicalofadenomyosis.Thereisalsoasmallwhiteleiomyomaatthelowerleft.Thethickenedandspongyappea37子宮平滑肌瘤:鐘剛-課件38Thisadenocarcinomaoftheendometriumismoreobvious.Irregularmassesofwhitetumorareseenoverthesurfaceofthisuterusthathasbeenopenedanteriorly.Thecervixisatthebottomofthepicture.Thisenlargeduteruswasnodoubtpalpableonphysicalexamination.Thisadenocarcinomaoftheend39AbnormalityofuterusAbnormalityofuterus40TreatmentFollowuphormonaltreatmentfibroidembolisationSurgicalmanagementhysterectomymyomectomymyolysisTreatmentFollowup41TreatmentFollowup:themajorityofpatientswithuterinemyomasdonotrequiresurgicaltreatment.SmalltumorsandnotcausingsymptomsPatientsinthelatereproductiveorperimenopausalyears.Management:repeatpelvicexminationsandassistedbyserialpelvicultrasoundmeasurementsEvery3-6months.TreatmentFollowup:themajori42TreatmentDrugtherapy:bleedingisnotheavyenoughtocauseanemiaandsmallmyoma.Mechanisms:PharmacologicinhibitionofestrogensecretionAnattemptmaybemadetominimizeuterinebleedingThistreatmentiscommonlyusedfor3to6months.TreatmentDrugtherapy:43TreatmentDrugsandrogenGnRH-asupplementation.GestrinoneMifepristoneChinesemedicineTreatme

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論